Structures by: Nanubolu J. B.
Total: 135
Thymine--catechol (1/1)
C5H6N2O2,C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9132(8)Å b=8.9917(10)Å c=36.898(4)Å
α=90° β=90° γ=90°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate xylene monosolvate
C27H21BrO6,C8H10
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.2587(6)Å b=12.7841(9)Å c=15.6238(11)Å
α=66.4460(10)° β=76.6340(10)° γ=86.0300(10)°
Methyl 2-{3-[(<i>tert</i>-butoxycarbonyl)amino]-1-methyl-2-oxoindolin-3-yl}-2-methoxy-2-phenylacetate
C24H28N2O6
Acta Crystallographica Section C (2015) 71, 4 322-329
a=16.7030(13)Å b=8.0515(6)Å c=17.0919(13)Å
α=90° β=90° γ=90°
Methyl 2-{3-[(<i>tert</i>-butoxycarbonyl)amino]-1-methyl-2-oxoindolin-3-yl}-2-[(4-methoxybenzyl)oxy]-2-phenylacetate
C31H34N2O7
Acta Crystallographica Section C (2015) 71, 4 322-329
a=13.9402(12)Å b=16.5380(15)Å c=14.3279(13)Å
α=90° β=116.0420(10)° γ=90°
Methyl 2-[(anthracen-9-yl)methoxy]-2-{3-[(<i>tert</i>-butoxycarbonyl)amino]-1-methyl-2-oxoindolin-3-yl}-2-phenylacetate
C38H36N2O6
Acta Crystallographica Section C (2015) 71, 4 322-329
a=18.2606(17)Å b=9.8976(9)Å c=18.5364(17)Å
α=90° β=99.310(2)° γ=90°
6,8-dinitro-2,4-dihydro-1<i>H</i>- benzo[<i>b</i>][1,2,4]triazolo[4,3-<i>d</i>][1,4]oxazin-1-one
C9H5N5O6
Acta Crystallographica Section C (2012) 68, 8 o302-o307
a=6.6313(4)Å b=18.5174(11)Å c=8.3354(5)Å
α=90.00° β=91.3520(10)° γ=90.00°
(<i>E</i>)-2-(2-hydroxy-4-oxopent-2-en-3-yl)-6,8-dinitro-2,4-dihydro- 1<i>H</i>-benzo[<i>b</i>][1,2,4]triazolo[4,3-<i>d</i>][1,4]oxazin-1-one
C14H11N5O8
Acta Crystallographica Section C (2012) 68, 8 o302-o307
a=7.2636(8)Å b=17.673(2)Å c=12.0447(13)Å
α=90.00° β=90.00° γ=90.00°
Cytosine
C4H5N3O
Acta Crystallographica Section C (2015) 71, 2
a=15.1040(10)Å b=15.1212(10)Å c=9.2948(6)Å
α=90° β=90° γ=90°
Frovatriptan succinate monohydrate
C14H18N3O,C4H5O4,H2O
Acta Crystallographica Section C (2013) 69, 4 428-435
a=10.6206(6)Å b=7.9939(5)Å c=22.3916(13)Å
α=90.00° β=92.8840(10)° γ=90.00°
Frovatriptan acetate
C14H18N3O,C2H3O2
Acta Crystallographica Section C (2013) 69, 4 428-435
a=11.2397(8)Å b=16.7124(13)Å c=8.6528(6)Å
α=90.00° β=96.1500(10)° γ=90.00°
Lapatinb monotosylate
C29H27ClFN4O4S,C7H7O3S
Acta Crystallographica Section C (2013) 69, 12 1516-1523
a=5.7828(4)Å b=20.7395(14)Å c=29.4867(19)Å
α=90.00° β=90.00° γ=90.00°
Lapatinib ditosylate
C29H28ClFN4O4S2,2(C7H7O3S)
Acta Crystallographica Section C (2013) 69, 12 1516-1523
a=9.2122(6)Å b=13.2387(9)Å c=18.3758(12)Å
α=95.3870(10)° β=92.4630(10)° γ=100.3590(10)°
Lamotriginium 4-methylbenzoate <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C9H7.41Cl2N5,C8H7.59O2,C3H7NO
Acta Crystallographica Section C (2013) 69, 10 1164-1169
a=9.3976(12)Å b=24.904(3)Å c=10.2105(14)Å
α=90.00° β=108.976(3)° γ=90.00°
Lamotriginium 4-iodobenzoate <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C9H7.54Cl2N5,C7H4.46IO2,C3H7NO
Acta Crystallographica Section C (2013) 69, 10 1164-1169
a=9.7282(6)Å b=24.9148(16)Å c=10.0307(6)Å
α=90.00° β=108.6180(10)° γ=90.00°
Lamotriginium 3,5-dinitro-2-hydroxybenzoate <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C9H8Cl2N5,C7H3N2O7,C3H7NO
Acta Crystallographica Section C (2013) 69, 10 1164-1169
a=10.0227(5)Å b=10.5507(5)Å c=12.5359(6)Å
α=81.8580(10)° β=71.8880(10)° γ=70.0090(10)°
2-Thioureido-1<i>H</i>-benzimidazol-3-ium chloride monohydrate
C8H9N4S,Cl,H2O
Acta Crystallographica Section E (2014) 70, 5 o553
a=9.3027(6)Å b=8.7038(5)Å c=14.5503(8)Å
α=90.00° β=109.143(3)° γ=90.00°
Dimethyl 5-chloro-2-oxo-5',6',7',7a'tetrahydrospiro[indoline-3,3'-pyrrolizine]-1',2'-dicarboxylate
C18H17ClN2O5
ACS combinatorial science (2017) 19, 10 633-639
a=9.060(2)Å b=10.055(2)Å c=10.287(3)Å
α=81.458(4)° β=72.948(4)° γ=86.293(4)°
Diethyl 5-chloro-5'-isobutyl-2-oxo-1-(2-oxo-2-phenylethyl)-1',5'-dihydrospiro[indoline-3,2'-pyrrole]-3',4'-dicarboxylate
C29H31Cl1N2O6
ACS combinatorial science (2017) 19, 10 633-639
a=15.58(3)Å b=10.475(15)Å c=35.30(5)Å
α=90° β=99.07(3)° γ=90°
N-(tert-butyl)-2-(7-methoxy-1-oxo-9-phenyl-1,3-dihydro-2H-pyrrolo[3,4-b]quinolin-2-yl)-2-(4-methoxyphenyl)acetamide
C31H31N3O4
ACS combinatorial science (2017) 19, 9 600-608
a=10.579(2)Å b=11.195(2)Å c=11.534(2)Å
α=86.716(3)° β=76.764(3)° γ=88.392(3)°
2(C19H14N4O5)
2(C19H14N4O5)
ACS omega (2018) 3, 10 12349-12360
a=10.5066(7)Å b=35.890(3)Å c=9.3401(7)Å
α=90° β=103.633(4)° γ=90°
Ethyl 5'-fluoro-3-(4-methoxyphenyl)-2'-oxospiro[cyclopropane-1,3'-indoline]-2-carboxylate
C20H18FNO4
ACS omega (2018) 3, 10 12349-12360
a=6.081(5)Å b=12.345(11)Å c=22.898(16)Å
α=90° β=93.02(2)° γ=90°
14-(4-ethylbenzoyl)-4a,8-dimethyl-3,4,4a,6,7,13a-hexahydro-4,7-methanobenzo[2,3][1,4]oxazepino[4,5- a]indol-2(1 H)-one
C28H29NO3
ACS Catalysis (2019) 10012
a=19.6581(13)Å b=8.4966(4)Å c=27.1209(15)Å
α=90° β=90° γ=90°
Ethyl 2-(3-acetyl-4-(3-nitrophenyl)-5-(4-nitrophenyl)-1H-pyrazol-1-yl)acetate
C21H18N4O7
The Journal of organic chemistry (2015) 80, 9 4325-4335
a=10.6542(8)Å b=23.6126(17)Å c=9.1002(6)Å
α=90.00° β=109.1290(10)° γ=90.00°
3-METHYL-1-PHENYL-[1,3]DIOXOLO[4,5,6,7]CHROMENO[2,3-c]PYRAZOL-4(1H)-ONE
C18H12N2O4
The Journal of organic chemistry (2017) 82, 6 2926-2934
a=4.438(4)Å b=10.210(10)Å c=15.70(2)Å
α=100.87(6)° β=95.25(5)° γ=93.71(3)°
(±)-(1S,3R,6R)-1,3-Bis(2,6-dichlorophenyl)-7,9-dimethoxy-5,6-dimethyl-1,3,4,6-tetrahydroindeno[7,1-cd]oxepine
C28H24Cl4O3
The Journal of organic chemistry (2019) 84, 12 7815-7828
a=7.8869(4)Å b=9.3365(5)Å c=19.4770(11)Å
α=81.863(2)° β=80.9818(17)° γ=65.5329(17)°
(±)-(1S,3R,6R)-7,9-Dimethoxy-5,6-dimethyl-1,3-diphenyl-1,3,4,6-tetrahydroindeno[7,1-cd]oxepine
C28H28O3
The Journal of organic chemistry (2019) 84, 12 7815-7828
a=9.206(7)Å b=10.422(9)Å c=13.489(11)Å
α=70.70(3)° β=86.07(3)° γ=64.49(4)°
C17H13N3S
C17H13N3S
The Journal of organic chemistry (2020)
a=8.285(3)Å b=14.446(5)Å c=12.198(4)Å
α=90° β=90° γ=90°
C19H18N2O2S
C19H18N2O2S
The Journal of organic chemistry (2020)
a=7.6361(15)Å b=8.1452(15)Å c=14.722(3)Å
α=95.298(6)° β=90.260(7)° γ=113.046(6)°
C18H16N2O2S
C18H16N2O2S
The Journal of organic chemistry (2020)
a=8.3698(18)Å b=10.5488(19)Å c=10.695(2)Å
α=66.788(5)° β=75.559(6)° γ=76.436(5)°
C26H20FNO2
C26H20FNO2
The Journal of organic chemistry (2020)
a=8.920(8)Å b=13.754(12)Å c=17.019(17)Å
α=90° β=103.67(2)° γ=90°
(Z)-4-benzylidene-3-(4-chlorophenyl)-1-oxa-3-azaspiro[4.5]decan-2-one'
C21H20ClNO2
The Journal of organic chemistry (2018) 83, 24 15186-15194
a=27.583(2)Å b=13.6001(10)Å c=10.2013(10)Å
α=90° β=104.589(4)° γ=90°
(Z)-4'-benzylidene-3'-(4-chlorophenyl)-1-methylspiro[indoline-3,5'-oxazolidine]-2,2'-dione
C24H17ClN2O3
The Journal of organic chemistry (2018) 83, 24 15186-15194
a=6.16338(8)Å b=33.2578(5)Å c=9.94383(14)Å
α=90° β=100.2051(8)° γ=90°
Methyl 2-{3-[(<i>tert</i>-butoxycarbonyl)amino]-1-methyl-2-oxoindolin-3-yl}-2-ethoxy-2-phenylacetate
C25H30N2O6
Acta Crystallographica Section C (2015) 71, 4 322-329
a=11.2274(14)Å b=13.3892(17)Å c=16.849(2)Å
α=91.475(2)° β=92.646(2)° γ=106.889(2)°
Bis(frovatriptan) succinate trihydrate
2(C14H18N3O),C4H4O42,3(H2O)
Acta Crystallographica Section C (2013) 69, 4 428-435
a=8.7239(11)Å b=18.662(2)Å c=10.1270(13)Å
α=90.00° β=96.098(2)° γ=90.00°
C17H15N3O2S
C17H15N3O2S
The Journal of organic chemistry (2020)
a=36.176(5)Å b=5.6425(8)Å c=15.396(2)Å
α=90° β=104.478(6)° γ=90°